6 results match your criteria: "China. wu.duojiao@zs-hospital.sh.cn.[Affiliation]"
Cell Biol Toxicol
December 2023
Jinshan Hospital Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
We present an integrated analysis of the clinical measurements, immune cells, and plasma lipidomics of 2000 individuals representing different age stages. In the study, we explore the interplay of systemic lipids metabolism and circulating immune cells through in-depth analysis of immune cell phenotype and function in peripheral dynamic lipids environment. The population makeup of circulation lymphocytes and lipid metabolites changes dynamically with age.
View Article and Find Full Text PDFCell Biol Toxicol
June 2023
Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China.
Background: With the advent of immune checkpoint inhibitors (ICIs) therapies, a major breakthrough has been made in cancer treatment. However, instead of good results, some patients experienced a deterioration of their disease. This unexpected result is termed as hyper-progressive disease (HPD).
View Article and Find Full Text PDFCell Biol Toxicol
June 2021
Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
CD8T cells play an important role in controlling infections and tumorigenesis in vivo. naïve CD8T cells exponentially expand and exert effector functions in response to TCR ligation. After antigen clearance, most effector CD8T cells (Teff) experience activation-induced cell death, only a small portion becomes long-lived memory T cells (Tmem).
View Article and Find Full Text PDFCell Biol Toxicol
August 2018
Zhongshan Hospital Institute of Clinical Science, Shanghai Institute of Clinical Bioinformatics; Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
The root of Actinidia chinensis, as traditional Chinese medicine, has been shown to inhibit cell proliferation in numerous cancer cells. However, the mechanisms underlying its inhibitory activity remain unclear. Death rates of hepatocellular carcinoma (HCC) are increasing, but therapies for advanced HCC are not well developed.
View Article and Find Full Text PDFAdv Exp Med Biol
April 2019
Zhongshan Hospital Institute of Clinical Science, Fudan University, Shanghai Institute of Clinical Bioinformatics, Shanghai, China.
During an immune response, leukocytes undergo major changes in growth and function that are tightly coupled to dynamic shifts in metabolic processes. Immunometabolism is an emerging field that investigates the interplay between immunological and metabolic processes. The immune system has a key role to play in controlling cancer initiation and progression.
View Article and Find Full Text PDFCell Biol Toxicol
August 2016
Shanghai Key Laboratory of Organ Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
For end-stage renal diseases, kidney transplantation is the most efficient treatment. However, the unexpected rejection caused by inflammation usually leads to allograft failure. Thus, a systems-level characterization of inflammation factors can provide potentially diagnostic biomarkers for predicting renal allograft rejection.
View Article and Find Full Text PDF